Scarica l'app Stockscreener
0.307
5.83%
-0.019
Precedente Chiudi:
$0.326
Aprire:
$0.321
Volume 24 ore:
1.01M
Relative Volume:
0.17
Capitalizzazione di mercato:
$9.10M
Reddito:
-
Utile/perdita netta:
$-14.58M
Rapporto P/E:
-0.267
EPS:
-1.15
Flusso di cassa netto:
$-9.80M
1 W Prestazione:
-24.37%
1M Prestazione:
-37.47%
6M Prestazione:
-57.98%
1 anno Prestazione:
-85.65%
Intervallo 1D:
$0.2907
$0.3226
Intervallo di 1 settimana:
$0.2907
$0.4326
Portata 52W:
$0.2907
$2.39
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Nome
Acurx Pharmaceuticals Inc
Settore
Industria
Telefono
917-533-1469
Indirizzo
259 LIBERTY AVENUE, STATEN ISLAND
Confronta ACXP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
0.307 | 9.66M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Acurx Pharmaceuticals Inc Borsa (ACXP) Ultime notizie
What institutional investors are buying Acurx Pharmaceuticals Inc. stockOutstanding risk-reward balance - jammulinksnews.com
Acurx Pharmaceuticals Inc. Stock Analysis and ForecastBuild a portfolio that stands the test of time - jammulinksnews.com
What makes Acurx Pharmaceuticals Inc. stock price move sharplyAchieve consistent profits with proven methods - jammulinksnews.com
Is Acurx Pharmaceuticals Inc. stock overvalued or undervaluedDynamic profit expansion - jammulinksnews.com
How volatile is Acurx Pharmaceuticals Inc. stock compared to the marketAchieve breakthrough investment performance - jammulinksnews.com
Acurx Implements 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing - AInvest
What are the latest earnings results for Acurx Pharmaceuticals Inc.Explosive capital appreciation - jammulinksnews.com
How strong is Acurx Pharmaceuticals Inc. company’s balance sheetFree Stock Chart Pattern Guide - jammulinksnews.com
Is it the right time to buy Acurx Pharmaceuticals Inc. stockDiscover market opportunities others miss - jammulinksnews.com
Does Acurx Pharmaceuticals Inc. stock perform well during market downturnsHigh-yield capital appreciation - jammulinksnews.com
What are analysts’ price targets for Acurx Pharmaceuticals Inc. in the next 12 monthsInvest smarter with data-backed insights - jammulinksnews.com
What is the dividend policy of Acurx Pharmaceuticals Inc. stockValue Investing Report For 2025 - jammulinksnews.com
Acurx Pharmaceuticals To Carry Out 1-for-20 Reverse Stock Split On August 5th, 2025 - 富途牛牛
Heatmap analysis for Acurx Pharmaceuticals Inc. and competitorsPrice Action Summary and Entry Strategy Guide - Newser
Why Acurx Pharmaceuticals Inc. stock attracts strong analyst attentionDaily Exit and Entry Price Prediction - Newser
Company’s Banking Shares: Up -87.00% from 52-Week Low, But Can the Momentum Hold? - investchronicle.com
How does Acurx Pharmaceuticals Inc. compare to its industry peersLow Risk Forecasts For Beginners - jammulinksnews.com
Why is Acurx Pharmaceuticals Inc. stock attracting strong analyst attentionPre Market Review For Consistent Profits - jammulinksnews.com
Should I hold or sell Acurx Pharmaceuticals Inc. stock in 2025Top Growth Tracker With Low Risk - jammulinksnews.com
How Acurx Pharmaceuticals Inc. stock performs during market volatilityAI-Based Reversal Point Prediction Signal - Newser
Multi asset correlation models including Acurx Pharmaceuticals Inc.Swing Gain Strategy with Entry Forecast - Newser
How moving averages guide Acurx Pharmaceuticals Inc. tradingFree AI Forecast for Trending Stocks - Newser
Technical signs of recovery in Acurx Pharmaceuticals Inc.Value Investing Summary and Earnings Outlook - Newser
Acurx Pharmaceuticals Approves Reverse Stock Split to Regain Nasdaq Compliance - AInvest
Acurx Pharmaceuticals Announces 1-For-20 Reverse Stock Split, Trading Post-Split On August 5, 2025 - 富途牛牛
Acurx Pharmaceuticals Plans Major 1:20 Reverse SplitKey Details for Nasdaq Compliance - Stock Titan
Can volume confirm reversal in Acurx Pharmaceuticals Inc.Free Daily Top Performing Stock Insights - Newser
What risks could impact Acurx Pharmaceuticals Inc. stock performanceStock Portfolio Risk and Return Analysis - Newser
Sector Rotation Brings Acurx Pharmaceuticals Inc. Into FocusTriple Digit Return Stock Predictions Released - metal.it
Can Acurx Pharmaceuticals Inc. Regain Lost Ground This QuarterRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Published on: 2025-07-29 10:12:38 - metal.it
Acurx Pharmaceuticals Inc. Rebound Backed by Sentiment ShiftWatchlist for Smart Swing Trading Updated - metal.it
What high frequency data says about Acurx Pharmaceuticals Inc.Intraday Price Forecast Using Volume Models - Newser
What are Acurx Pharmaceuticals Inc. company’s key revenue driversAchieve rapid capital gains with smart investing - jammulinksnews.com
Acurx Pharmaceuticals Inc Azioni (ACXP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):